Search alternatives:
significantly increased » significant increase (Expand Search)
increased decrease » increased release (Expand Search), increased crash (Expand Search)
green decrease » greater decrease (Expand Search), teer decrease (Expand Search), greatest decrease (Expand Search)
significantly increased » significant increase (Expand Search)
increased decrease » increased release (Expand Search), increased crash (Expand Search)
green decrease » greater decrease (Expand Search), teer decrease (Expand Search), greatest decrease (Expand Search)
-
841
-
842
Activity of xylanase in mixed feed and liver (mg saccharide/g sample/h), n = 12/treatment.
Published 2024Subjects: -
843
-
844
-
845
-
846
-
847
CaCl<sub>2</sub> and MnCl<sub>2</sub> treatment significantly reduced Pol I occupancy on the rDNA template.
Published 2025“…If the <i>p</i>-value < 0.05, that was deemed a significant difference between the two treatment groups and was indicated with either a green (increased occupancy) or black (decreased occupancy) line below the histogram for the CaCl<sub>2</sub> treated samples with respect to the untreated samples. …”
-
848
-
849
-
850
-
851
Linear covariate analysis of prognostically significant metabolites. Presenting the effect sizes of metabolites that showed significant differences among prognostic groups in ICU-treated COVID-19 patients. Metabolites were included based on an F-value > 2.5 and a p-value < 0.05. Metabolites marked with a single asterisk (*) were significant in both two-way ANOVA and ASCA, whereas those marked with double asterisks (**) were significant only in two-way ANOVA. Positive effect sizes indicate an increase in metabolite concentration between the compared groups, while negative values indicate a decrease.
Published 2025“…Positive effect sizes indicate an increase in metabolite concentration between the compared groups, while negative values indicate a decrease.…”
-
852
-
853
-
854
-
855
-
856
-
857
-
858
Summary of post-treatment disease course measures from MDMA-AT publications.
Published 2025Subjects: -
859
-
860
Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications.
Published 2025Subjects: